New study aims to better predict signs of cancer

17 October 2012

Researchers at the University of Southampton are to take part in a thorough study in order to better predict the risk of someone developing cancer.

The clinical information and blood samples of 20,000 people who have suffered from lung or colon cancer will be collected and analysed as part of the research.

During the process, the study team, which will be led by Paul Little, professor of primary care research at the institute, intends to look for signs and symptoms that are most predictive of patients who go on to be diagnosed with cancer.

The CANcer DIagnosis Decision rules study will cost £2 million to undertake, with funding being provided by the National Institute for Health Research School for Primary Care Research (NIHR SPCR).

Professor Richard Hobbs, director of NIHR SPCR, commented: "The NIHR School for Primary Care Research is pleased to be supporting this ambitious new study, the funding for which was made possible after we had redesigned the way that the School funds its research to enable larger, collaborative, longer term research to compete with short term single centre studies."

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)